Aminobenzoic acid and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Aminobenzoic acid (para - aminobenzoic acid (paba)), especially for people who are male, 60+ old, also take Acetaminophen, and have Pulmonary embolism.

The study is created by eHealthMe based on reports of 459 people who have side effects when taking Aminobenzoic acid from the FDA, and is updated regularly.

What is Aminobenzoic acid?

Aminobenzoic acid has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 462 Aminobenzoic acid users. Check the latest studies of Aminobenzoic acid.

On Apr, 27, 2026

459 people reported to have side effects when taking Aminobenzoic acid.
Among them, 64 people (13.94%) died.

Among these 64 people:

What is the gender of people who died when taking Aminobenzoic acid? *

female: 3.45 %
male: 96.55 %

What is the age of people who died when taking Aminobenzoic acid? *

What are other drugs people take besides Aminobenzoic acid? *

What are other side effects people have before they died? *

Sepsis (a severe blood infection that can lead to organ failure and death): 58 people, 90.62%
Cardiogenic Shock (inadequate circulation of blood): 56 people, 87.50%
Abdominal Distension: 55 people, 85.94%
Nausea And Vomiting: 55 people, 85.94%
Stress And Anxiety: 55 people, 85.94%
Ventricular Fibrillation (abnormally irregular heart rhythm): 54 people, 84.38%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 54 people, 84.38%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 53 people, 82.81%
Blood Phosphorus Increased: 52 people, 81.25%
Drowsiness: 52 people, 81.25%

What are the existing conditions these people have? *

Anaemia (lack of blood): 62 people, 96.88%
Ventricular Fibrillation (abnormally irregular heart rhythm): 62 people, 96.88%
Dyspnea (difficult or laboured breathing): 62 people, 96.88%
Diabetes: 62 people, 96.88%
Iron Deficiency: 62 people, 96.88%
Constipation: 62 people, 96.88%
Nausea (feeling of having an urge to vomit): 62 people, 96.88%
Nausea And Vomiting: 62 people, 96.88%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 62 people, 96.88%
Pulmonary Embolism (blockage of the main artery of the lung): 62 people, 96.88%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminobenzoic acid:

Aminobenzoic acid (462 reports)

Expand to all the drugs that have ingredients of para - aminobenzoic acid (paba):

Death and drugs with ingredients of para - aminobenzoic acid (paba) (96 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aminobenzoic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,126 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on para - aminobenzoic acid (paba) (the active ingredients of Aminobenzoic acid) and Aminobenzoic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.